Simmons & Simmons advised Eisai on the divestment. Eisai S.A.S, the French subsidiary of Eisai Co., Ltd., has transferred its rights to Loxapac (loxapine) and Parkinane...
CNX Therapeutics’ €56.5m Acquisition of Eisai’s Rights in Loxapac and Parkinane
Balt International SAS’ Joint Venture With ab medica S.p.A. To Create Balt Italy
IN BRIEF: Gianni & Origoni, Simmons & Simmons, advised on the matter. Gianni & Origoni advised ab medica with a team including Gherardo Cadore (Corporate M&A),...
Balt International SAS’ Joint Venture With ab medica S.p.A. To Create Balt Italy
IN BRIEF: Gianni & Origoni, Simmons & Simmons, advised on the matter. Gianni & Origoni advised ab medica with a team including Gherardo Cadore (Corporate M&A),...